Resources from the same session
981O - Hepatic arterial infusion chemotherapy (HAIC) with oxaliplatin, fluorouracil, and leucovorin (FOLFOX) versus transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (HCC): A randomised phase III trial
Presenter: Ming Shi
Session: Proffered Paper - GI, non colorectal
Resources:
Abstract
Slides
Webcast
LBA65 - The Canadian Cancer Trials Group PA.7 trial: Results of a randomized phase II study of gemcitabine (GEM) and nab-paclitaxel (Nab-P) vs GEM, nab-P, durvalumab (D) and tremelimumab (T) as first line therapy in metastatic pancreatic ductal adenocarcinoma (mPDAC)
Presenter: Daniel Renouf
Session: Proffered Paper - GI, non colorectal
Resources:
Abstract
Slides
Webcast
1525O - The QOLIXANE trial - Real life QoL and efficacy data in 1st line pancreatic cancer from the prospective platform for outcome, quality of life, and translational research on pancreatic cancer (PARAGON) registry
Presenter: Thorsten Götze
Session: Proffered Paper - GI, non colorectal
Resources:
Abstract
Slides
Webcast
Q&A and live discussion
Presenter: Salah-Eddin Al-Batran
Session: Proffered Paper - GI, non colorectal
Resources:
Webcast
Invited Discussant LBA65 and 1525O
Presenter: Eileen O'Reilly
Session: Proffered Paper - GI, non colorectal
Resources:
Slides
Webcast